Skip to main content
. 2020 Aug 11;21(16):5774. doi: 10.3390/ijms21165774
CTLA-4 T-lymphocyte-associated protein 4
PD-1 Programmed cell death protein 1
ICIs Immune checkpoint inhibitors
irAEs Immune related adverse events
NirAEs Neurological immune-related adverse events
CNS Central nervous system
Tregs Regulatory T-cells
APCs Antigen-presenting cells
PNS Paraneoplastic syndrome
NMDAR N-methyl-D-aspartate receptor
ES Epitope spreading
NSCLC Non-small cell lung cancer
Mab Monoclonal antibodies